GillHSDeVaneLRischC. Extrapyramidal symptoms associated with cyclic antidepressant treatment: A review of the literature and consolidating hypotheses. J Clin Psychopharmacol1997;17:377–89.
2.
LeoRJ. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry1996;57:449–54.
3.
CaleyCF. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors. Ann Pharmacother1997;31:1481–9.
4.
GerberPELyndLD. Selective serotonin-reuptake inhibitor—induced movement disorders. Ann Pharmacother1998;32:692–8.
5.
LeoRJ. Clinical manifestations of dystonia and dyskinesia after SSRI administration (letter). J Clin Psychiatry1997;58:403–4.
6.
BudmanCLBruunRD. Persistent dyskinesia in a patient receiving fluoxetine (letter). Am J Psychiatry1991;148:1403.
7.
Al-AdwaniA. Brain damage and tardive dyskinesia (letter). Br J Psychiatry1995;167:410–1.
8.
CoulterDMPillansPI. Fluoxetine and extrapyramidal side effects. Am J Psychiatry1995;152:122–5.
9.
MaanyIDhopeshV. Akathisia and fluoxetine (letter). J Clin Psychiatry1990;51:210.
10.
AmsterdamJDHornig-RohanMMaislinG. Efficacy of alprazolam in reducing fluoxetine-induced jitteriness in patients with major depression. J Clin Psychiatry1994;55:394–400.
11.
SteurENHJ. Increase of parkinson disability after fluoxetine medication. Neurology1993;43:211–3.
12.
Jimenez-JimenezFJTejeiroJMartinez-JunqueraGCabrera-ValdiviaFGarcia-AlbeaE. Parkinsonism exacerbated by paroxetine. Neurology1994;44:2406.
13.
ReccoppaLWelchWAWareMR. Acute dystonia and fluoxetine (letter). J Clin Psychiatry1990;51:487.
14.
DrayA. Serotonin in the basal ganglia: Functions and interactions with other neural pathways. J Physiol Paris1981;77:393–403.
15.
DurifFVidailhetMBonnetAMBlinJAgidY. Levodopa-induced dyskinesias are improved by fluoxetine. Neurology1995;45:1855–8.
16.
SchreiberSPickCG. Fluoxetine for blepharospasm: Interaction of serotonin and dopamine. J Nerv Ment Dis1995;183:719–21.
17.
FibigerHCLloydKG. Neurobiological substrates of tardive dyskinesia: The GABA hypothesis. Trends Neurosci1984;7:462–4.
18.
OzdemirVNaranjoCAHerrmannNReedKSellersEMKalowW. Paroxetine potentiates the central nervous system side effects of perphenazine: Contribution of cytochrome P4502D6 inhibition in vivo. Clin Pharmacol Ther1997;62:334–47.
19.
LeoRJLichterDGHersheyLA. Parkinsonism associated with fluoxetine and cimetidine: A case report. J Geriatr Psychiatry Neurol1995;8:231–3.
20.
WeissmanMWKlermanGL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry1977;34:98–111.
